Mayo validates COVID-19 plasma treatment as public seeks vaccine
January 14, 2021
Donor plasma from patients who have recovered from COVID-19 can reduce deaths in others if given early and at high enough doses, Mayo Clinic researchers found.
The discovery validates one of COVID-19's only known treatments, which will be relied on until an increase in vaccinations snuffs out the global pandemic, said Dr. R. Scott Wright, a coordinator of Mayo's national COVID-19 plasma therapy program.
"I think it behooves the medical community to continue to innovate and test therapies for treatment. Realistically, we're months away from having a substantial number of people vaccinated," Wright said.